tiprankstipranks
Trending News
More News >
Celldex reports Q1 EPS (81c), consensus (74c)
PremiumThe FlyCelldex reports Q1 EPS (81c), consensus (74c)
1d ago
Optimistic Buy Rating for Celldex Driven by Promising Barzolvolimab Developments and Strong Financial Position
Premium
Ratings
Optimistic Buy Rating for Celldex Driven by Promising Barzolvolimab Developments and Strong Financial Position
4d ago
Promising Phase 2 Results for Celldex’s Barzolvolimab in Eosinophilic Esophagitis Boosts Buy Rating
Premium
Ratings
Promising Phase 2 Results for Celldex’s Barzolvolimab in Eosinophilic Esophagitis Boosts Buy Rating
4d ago
Celldex initiated with an Overweight at Morgan Stanley
PremiumThe FlyCelldex initiated with an Overweight at Morgan Stanley
2M ago
Celldex’s Barzolvolimab: Promising Phase 2 Results and Strong Buy Rating
Premium
Ratings
Celldex’s Barzolvolimab: Promising Phase 2 Results and Strong Buy Rating
2M ago
Celldex presents preclinical data from CDX-622 at AAAAI 2025
Premium
The Fly
Celldex presents preclinical data from CDX-622 at AAAAI 2025
2M ago
Celldex Buy Rating: Promising Clinical Advancements and Strong Financial Position Drive Positive Outlook
PremiumRatingsCelldex Buy Rating: Promising Clinical Advancements and Strong Financial Position Drive Positive Outlook
2M ago
Celldex reports Q4 EPS (71c), consensus (71c)
Premium
The Fly
Celldex reports Q4 EPS (71c), consensus (71c)
2M ago
Celldex initiated with a Buy at UBS
Premium
The Fly
Celldex initiated with a Buy at UBS
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100